- Home
- CHE
CHE
Chemed Corp
as 02-21-2025 4:00pm EST
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
Upcoming Earnings Alert:
Get ready for potential market movements as Chemed Corp CHE prepares to release earnings report on 26 Feb 2025.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 8.4B | IPO Year: | N/A |
| Target Price: | $641.50 | AVG Volume (30 days): | 91.9K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 19.78 | EPS Growth: | 22.57 |
| 52 Week Low/High: | $512.12 - $654.62 | Next Earning Date: | 02-26-2025 |
| Revenue: | $2,377,206,000 | Revenue Growth: | 6.83% |
| Revenue Growth (this year): | 8.28% | Revenue Growth (next year): | 7.06% |
Stock Insider Trading Activity of Chemed Corp (CHE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Judkins Brian C | CHE | VP and Chief Legal Officer | Dec 30 '24 | Buy | $519.50 | 145 | $75,327.50 | 1,678 | |
| LEE SPENCER S | CHE | executive vice president | Nov 27 '24 | Sell | $575.62 | 732 | $421,356.04 | 18,287 | |
| MCNAMARA KEVIN J | CHE | president and CEO | Nov 25 '24 | Sell | $572.77 | 2,000 | $1,145,540.00 | 101,735 |
Latest Chemed Corp News
CHE Breaking Stock News: Dive into CHE Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
CHE: Lowering target price to $578.00
Business Wire
8 days ago
Chemed Corporation Declares Quarterly Dividend of 50 Cents
StockStory
8 days ago
Winners And Losers Of Q3: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
StockStory
8 days ago
Senior Health, Home Health & Hospice Stocks Q3 Results: Benchmarking Brookdale (NYSE:BKD)
StockStory
8 days ago
Q3 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
StockStory
9 days ago
Senior Health, Home Health & Hospice Stocks Q3 Teardown: The Pennant Group (NASDAQ:PNTG) Vs The Rest
Zacks
9 days ago
ADUS vs. CHE: Which Stock Is the Better Value Option?
StockStory
9 days ago
Senior Health, Home Health & Hospice Stocks Q3 Earnings Review: Option Care Health (NASDAQ:OPCH) Shines
Compare CHE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CHE Chemed Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.